386
Views
43
CrossRef citations to date
0
Altmetric
Articles

Gout and risk of non-alcoholic fatty liver disease

, , , , , , , , & show all
Pages 466-471 | Accepted 02 Mar 2010, Published online: 21 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qianjia Sun, Tingjing Zhang, Laeeqa Manji, Yashu Liu, Qing Chang, Yuhong Zhao, Yang Ding & Yang Xia. (2023) Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis. Clinical Epidemiology 15, pages 683-693.
Read now
MD Kontogianni, C Chrysohoou, DB Panagiotakos, E Tsetsekou, A Zeimbekis, C Pitsavos & C Stefanadis. (2012) Adherence to the Mediterranean diet and serum uric acid: the ATTICA study. Scandinavian Journal of Rheumatology 41:6, pages 442-449.
Read now

Articles from other publishers (41)

Naomi Schlesinger, Fernando Pérez-Ruiz & Frédéric Lioté. (2023) Mechanisms and rationale for uricase use in patients with gout. Nature Reviews Rheumatology.
Crossref
Ke Si, Jingwei Chi, Lili Xu, Bingzi Dong, Chuanfeng Liu, Ying Chen & Yangang Wang. (2023) The risk of nonalcoholic fatty liver disease in gout patients with frequent flares: a retrospective cohort study. Clinical Rheumatology 42:5, pages 1389-1395.
Crossref
Yiwei Hang, Christine Lee & Youssef M Roman. (2023) Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East Asian populations. Biomarkers in Medicine 17:8, pages 445-454.
Crossref
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu & Mindie H. Nguyen. (2022) 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 20:12, pages 2809-2817.e28.
Crossref
Sara E. Lewis, Lihua Li, Marco Fazzari, Sonia R. Salvatore, Jiang Li, Emily A. Hileman, Brooke A. Maxwell, Francisco J. Schopfer, Gavin E. Arteel, Nicholas K.H. Khoo & Eric E. Kelley. (2022) Obese female mice do not exhibit overt hyperuricemia despite hepatic steatosis and impaired glucose tolerance. Advances in Redox Research 6, pages 100051.
Crossref
Yu-kai Zhang, Jia-shu Chen, Min-min Wang, Chuan-zeng Wang, Mu-xuan Wang, Zhen Wang, Qin-liang Yang, Bin Sun, Jin-yue Sun, Yu-fa Liu & Chao Liu. (2022) Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effects. Bioorganic Chemistry 126, pages 105916.
Crossref
Yang Yang, Wei Xian, Dide Wu, Zijun Huo, Shubin Hong, Yanbing Li & Haipeng Xiao. (2022) The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study. Frontiers in Endocrinology 13.
Crossref
Mikhail E. Statsenko, Svetlana V. Turkina, Margarita N. Ustinova, Alexander V. Tumarenko, Oleg Y. Sviridenko & Anton O. Sviridenko. (2022) THE ROLE OF HYPERURICEMIA IN THE DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE. Journal of Volgograd State Medical University 19:2, pages 33-42.
Crossref
Chang'e Liu, Yingyue Liu, Xiaoyang Hong & Zhichun Feng. (2022) Study of the incidence of hyperuricemia in young males’ population with rapid entry into the plateau of 4 500m. Frigid Zone Medicine 2:1, pages 41-44.
Crossref
Wei Liu, Hui Song, Siliang Man, Hongchao Li & Siming Gao. (2021) Simple metabolic markers associated with tophaceous gout. Clinical Rheumatology 40:12, pages 5047-5053.
Crossref
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao & Jianfeng Bao. (2019) Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. Biomedicine & Pharmacotherapy 117, pages 109158.
Crossref
Jung Sun Lee, Jebum Won, Oh Chan Kwon, Seung Soo Lee, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo & Seokchan Hong. (2019) Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease. The Journal of Rheumatology 46:5, pages 527-531.
Crossref
Pascal Richette & Augustin Latourte. (2018) Hyperferritinaemia and hyperuricaemia — a causal connection?. Nature Reviews Rheumatology 14:11, pages 628-629.
Crossref
Thomas Jensen, Koichiro Niwa, Ichiro Hisatome, Mehmet Kanbay, Ana Andres-Hernando, Carlos A. Roncal-Jimenez, Yuka Sato, Gabriela Garcia, Minoru Ohno, Miguel A. Lanaspa, Richard J. Johnson & Masanari Kuwabara. (2018) Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver. Scientific Reports 8:1.
Crossref
B. Grygiel-Górniak, M. Mosor, J. Marcinkowska, J. Przysławski & J. Nowak. (2017) Uric acid and obesity-related phenotypes in postmenopausal women. Molecular and Cellular Biochemistry 443:1-2, pages 111-119.
Crossref
Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, Kristen J. Nadeau, Melanie Green, Carlos Roncal, Takahiko Nakagawa, Masanari Kuwabara, Yuka Sato, Duk-Hee Kang, Dean R. Tolan, Laura G. Sanchez-Lozada, Hugo R. Rosen, Miguel A. Lanaspa, Anna Mae Diehl & Richard J. Johnson. (2018) Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. Journal of Hepatology 68:5, pages 1063-1075.
Crossref
Chao Yang, Shujuan Yang, Weiwei Xu, Junhui Zhang, Wenguang Fu & Chunhong Feng. (2017) Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. PLOS ONE 12:5, pages e0177249.
Crossref
Collette E. Abbott, Ruliang Xu & Samuel H. Sigal. (2017) Colchicine-Induced Hepatotoxicity. ACG Case Reports Journal 4:1, pages e120.
Crossref
Junichiro Kumagai, Tatsuo Kanda, Shin Yasui, Yuki Haga, Reina Sasaki, Masato Nakamura, Shuang Wu, Shingo Nakamoto, Makoto Arai, Yotaro Iino & Osamu Yokosuka. (2016) Autoimmune hepatitis following drug-induced liver injury in an elderly patient. Clinical Journal of Gastroenterology 9:3, pages 156-159.
Crossref
Chang-Fu Kuo, Matthew J. Grainge, Christian Mallen, Weiya Zhang & Michael Doherty. (2016) Impact of gout on the risk of atrial fibrillation. Rheumatology 55:4, pages 721-728.
Crossref
Yong Tan, Xinru Liu, Ke Zhou, Xiaojuan He, Cheng Lu, Bing He, Xuyan Niu, Cheng Xiao, Gang Xu, Zhaoxiang Bian, Xianpeng Zu, Ge Zhang, Weidong Zhang & Aiping Lu. (2016) The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia. PLOS ONE 11:2, pages e0149043.
Crossref
Shulan Gong, Jiqing Song, Luan Wang, Shuaiqing Zhang & Yangang Wang. (2016) Hyperuricemia and risk of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 28:2, pages 132-138.
Crossref
Chang-Fu Kuo, Matthew J Grainge, Christian Mallen, Weiya Zhang & Michael Doherty. (2016) Comorbidities in patients with gout prior to and following diagnosis: case-control study. Annals of the Rheumatic Diseases 75:1, pages 210-217.
Crossref
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele & Giovanni Targher. (2015) Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 47:12, pages 997-1006.
Crossref
Ming-Hsiung Shih, Mariana Lazo, Su-Hsun Liu, Susanne Bonekamp, Ruben Hernaez & Jeanne M. Clark. (2015) Association between serum uric acid and nonalcoholic fatty liver disease in the US population. Journal of the Formosan Medical Association 114:4, pages 314-320.
Crossref
Chang-Fu Kuo, Matthew J Grainge, Lai-Chu See, Kuang-Hui Yu, Shue-Fen Luo, Weiya Zhang & Michael Doherty. (2015) Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Research & Therapy 17:1, pages 13.
Crossref
Chuan-Chin Lu, Shyi-Kuen Wu, Han-Yu Chen, Wei-Sheng Chung, Meng-Chih Lee & Chih-Jung Yeh. (2014) Clinical Characteristics of and Relationship Between Metabolic Components and Renal Function Among Patients with Early-onset Juvenile Tophaceous Gout. The Journal of Rheumatology 41:9, pages 1878-1883.
Crossref
Peter J Meffert, Sebastian E Baumeister, Markus M Lerch, Julia Mayerle, Wolfgang Kratzer & Henry Völzke. (2014) Development, External Validation, and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis. American Journal of Gastroenterology 109:9, pages 1404-1414.
Crossref
M. Birlik, O. Gurler, S. Akar, I. Sari, F. Onen & N. Akkoc. (2014) The prevalence of gout in an urban area of Izmir, Turkey: A population-based epidemiological study. International Journal of Clinical Practice 68:6, pages 775-782.
Crossref
Wen Cai, Jiang-mei Song, Bei Zhang, Yu-ping Sun, Hua Yao & Yue-xin Zhang. (2014) The Prevalence of Nonalcoholic Fatty Liver Disease and Relationship with Serum Uric Acid Level in Uyghur Population. The Scientific World Journal 2014, pages 1-7.
Crossref
Teruki Miyake, Teru Kumagi, Shinya Furukawa, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura & Morikazu Onji. (2013) Non‐alcoholic fatty liver disease: Factors associated with its presence and onset. Journal of Gastroenterology and Hepatology 28:S4, pages 71-78.
Crossref
Wen Cai, Xuan Wu, Bei Zhang, Lei Miao, Yu-ping Sun, Yuan Zou & Hua Yao. (2013) Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arquivos Brasileiros de Endocrinologia & Metabologia 57:8, pages 617-622.
Crossref
Nicola Dalbeth, Fernando Perez-Ruiz & Naomi SchlesingerMiguel MartilloElaine KarisDaria B CrittendenMichael H Pillinger. 2013. Gout. Gout 212 225 .
Jeffrey C. Sirota, Kim McFann, Giovanni Targher, Richard J. Johnson, Michel Chonchol & Diana I. Jalal. (2013) Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 62:3, pages 392-399.
Crossref
Chan Wah-Kheong & Goh Khean-Lee. (2012) Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. Hepatology International 7:1, pages 65-71.
Crossref
C.-F. Kuo, K.-H. Yu, L.-C. See, I.-J. Chou, Y.-S. Ko, H.-C. Chang, M.-J. Chiou & S.-F. Luo. (2012) Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology 52:1, pages 111-117.
Crossref
Miguel A. Lanaspa, Laura G. Sanchez-Lozada, Yea-Jin Choi, Christina Cicerchi, Mehmet Kanbay, Carlos A. Roncal-Jimenez, Takuji Ishimoto, Nanxing Li, George Marek, Murat Duranay, George Schreiner, Bernardo Rodriguez-Iturbe, Takahiko Nakagawa, Duk-Hee Kang, Yuri Y. Sautin & Richard J. Johnson. (2012) Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress. Journal of Biological Chemistry 287:48, pages 40732-40744.
Crossref
Miguel A. Lanaspa, Laura G. Sanchez-Lozada, Christina Cicerchi, Nanxing Li, Carlos A. Roncal-Jimenez, Takuji Ishimoto, Myphuong Le, Gabriela E. Garcia, Jeffrey B. Thomas, Christopher J. Rivard, Ana Andres-Hernando, Brandi Hunter, George Schreiner, Bernardo Rodriguez-Iturbe, Yuri Y. Sautin & Richard J. Johnson. (2012) Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver. PLoS ONE 7:10, pages e47948.
Crossref
Chia‐Chi Wang, Tai‐Chung Tseng, Tsung‐Cheng Hsieh, Ching‐Sheng Hsu, Pin‐Chao Wang, Hans Hsienhong Lin & Jia‐Horng Kao. (2012) Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. The Kaohsiung Journal of Medical Sciences 28:3, pages 151-160.
Crossref
Chang-Fu Kuo, Kuang-Hui Yu, Lai-Chu See, I-Jun Chou, Wen-Yi Tseng, Hsiao-Chun Chang, Yu-Ming Shen & Shue-Fen Luo. (2011) Elevated risk of mortality among gout patients: A comparison with the National Population in Taiwan. Joint Bone Spine 78:6, pages 577-580.
Crossref
Chang-Fu Kuo, Kuang-Hui Yu, Lai-Chu See, I-Jun Chou, Wen-Yi Tseng, Hsiao-Chun Chang, Yu-Ming Shen & Shue-Fen Luo. (2011) Risqué élevé de mortalité chez les patients goutteux : une comparaison avec la population nationale taïwanaise. Revue du Rhumatisme 78:5, pages 437-441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.